SB 415286

• Catalog No.: S3567
• CAS Number: 264218-23-7
• M. F.: C16H10ClN3O5
• M. W.: 359.7207
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione
• IUPAC Traditional name: 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione
• Synonyms: 3-[(3-Chloro-4-hydroxyphenyl)-amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione

DATABASE IDS

• PubChem SID: 24278412
• CAS Number: 264218-23-7
• MDL Number: MFCD04039789

PROPERTIES

• Empirical Formula (Hill Notation): C16H10N3O5Cl
• Purity: ≥98% (HPLC)
• Gene Information: human ... GSK3A(2931), GSK3B(2932)
• Apperance: yellow to orange
• Solubility: DMSO: soluble16 mg/mL
• Solubility: H2O: insoluble
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
Glycogen synthase kinase-3 (GSK-3) inhibitor.
Legal Information
Sold for research purposes under agreement from Glaxo-Smith-Kline

Description (简体中文)

Biochem/physiol Actions
Glycogen synthase kinase-3 (GSK-3) inhibitor.
Legal Information
Sold for research purposes under agreement from Glaxo-Smith-Kline